0
INTERNATIONAL MARKET DEVELOPMENT<br />VACCINES ,BIOLOGICS, SPECIALTY PHARMA, GENERICS, HOSPITAL SUPPLIES & DIAGNOSTICS<br ...
OUR CAPABILITIES IN GLOBAL MARKETS<br />GOVERNMENT (Public) MARKETS<br />PRIVATE MARKETS<br />AmbianceVentures<br />
International Distribution: Summary of  Services<br /><ul><li>Regulatory• Logistics: Customs, Warehousing & Cold Chain Sto...
Pharmacovigilance – Follow-up and tracking
 Bridging studies – Follow-up</li></ul>AmbianceVentures<br />
Terminology:<br />‘Approved’ / ‘Accredited’ / ‘Preferred Distributor’ <br />‘Govt. Authorized Agent’<br />‘Clearing & Forw...
Accredited bidders – Principal-to-Agent Agreement
Comply with paperwork for government tenders
Physical presence required during bid opening process
Negotiate bidding prices – 1 cent difference in price can win or lose tender!
Consolidation of local orders for differed deliveries, drop shipments.
Multiple agents for govt. bids, private markets , institutional markets
Staffing: 5 to 10 people specialized in customs , regulatory,  tenders,</li></ul>  logistics and other business functions....
REGULATORY  & LEGAL COMPLIANCE:<br /><ul><li>Filing initial application for Product Registration
Obtain required certification, licenses
Follow-up on application through multiple agencies
Submit samples, submit analytical, BE studies and clinical reports
Initiate bridging studies, periodic stability tests done locally </li></ul>  (follow-up and coordinate)<br /><ul><li>Prepa...
Registration with ‘local government’ (state / province)
Registration for private distribution in ‘cooperatives’</li></ul>AmbianceVentures<br />
REGULATORY & LEGAL COMPLIANCE:<br /><ul><li>Labeling requirements; Local / regional language translation
Periodic follow-up (weekly)
 Most Governments DO NOT OPEN Letters of Credit
Customs documentation is CRITICAL
Comply with specified product delivery criteria
INCOMPLETE OR INACCURATE DOCUMENTATION CAN RESULT IN INORDINATE DELAYS IN PRODUCT LAUNCH, OR OUTRIGHT REJECTION
Delays in product delivery and improper storage at govt. appointed </li></ul>facilities can result in damage, loss of pote...
PRIVATE MARKETS:<br />Influential in lobbying Federal and Provincial Governments, Regional Distributors<br /><ul><li>Agent...
Reputation in private market supply chain
Supply logistics, cold chain, customer service
Institutional : Large insurance companies, Hospital chains
Retail: Pharmacy chains
Wholesalers: Physician offices
National level programs through private clinics
 Create Local Advisory Boards; Strong connections with KOLs</li></ul>AmbianceVentures<br />
ACCOUNTS RECEIVABLES, COLLECTIONS:<br /><ul><li>Governments do not open Letters of Credit
Terms vary from 90 – 180 days credit
Sometimes bank guarantees can be obtained.
Assuming the Financial Risk  - Agents / Distributors are experienced in collections </li></ul> from both government and pr...
LOGISTICS:<br /><ul><li>Customs clearance – proper documentation
Upcoming SlideShare
Loading in...5
×

Global Mktg Presentation 3.0

891

Published on

Global Mktg. Capabilities Presentation - April 2010

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
891
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
24
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • Spain
  • Spain
  • Transcript of "Global Mktg Presentation 3.0"

    1. 1. INTERNATIONAL MARKET DEVELOPMENT<br />VACCINES ,BIOLOGICS, SPECIALTY PHARMA, GENERICS, HOSPITAL SUPPLIES & DIAGNOSTICS<br />AmbianceVentures<br />
    2. 2. OUR CAPABILITIES IN GLOBAL MARKETS<br />GOVERNMENT (Public) MARKETS<br />PRIVATE MARKETS<br />AmbianceVentures<br />
    3. 3. International Distribution: Summary of Services<br /><ul><li>Regulatory• Logistics: Customs, Warehousing & Cold Chain Storage• Local Order Processing• Collection, Accounts Receivables• Credit & Risk Management• Government and Private Sales• Repackaging & Labeling• Delivery & Transportation• Reverse Logistics – Returns, handling expired, obsolete product• Cross Docking• Sample Management
    4. 4. Pharmacovigilance – Follow-up and tracking
    5. 5. Bridging studies – Follow-up</li></ul>AmbianceVentures<br />
    6. 6. Terminology:<br />‘Approved’ / ‘Accredited’ / ‘Preferred Distributor’ <br />‘Govt. Authorized Agent’<br />‘Clearing & Forwarding Agent’<br />‘Warehousing Agent’ <br /><ul><li>Endorsement from Ministry of Health – ‘local’ bidders are preferred
    7. 7. Accredited bidders – Principal-to-Agent Agreement
    8. 8. Comply with paperwork for government tenders
    9. 9. Physical presence required during bid opening process
    10. 10. Negotiate bidding prices – 1 cent difference in price can win or lose tender!
    11. 11. Consolidation of local orders for differed deliveries, drop shipments.
    12. 12. Multiple agents for govt. bids, private markets , institutional markets
    13. 13. Staffing: 5 to 10 people specialized in customs , regulatory, tenders,</li></ul> logistics and other business functions. <br /><ul><li>Ward off competitors’ efforts for bids through counterproposals</li></ul>AmbianceVentures<br />
    14. 14. REGULATORY & LEGAL COMPLIANCE:<br /><ul><li>Filing initial application for Product Registration
    15. 15. Obtain required certification, licenses
    16. 16. Follow-up on application through multiple agencies
    17. 17. Submit samples, submit analytical, BE studies and clinical reports
    18. 18. Initiate bridging studies, periodic stability tests done locally </li></ul> (follow-up and coordinate)<br /><ul><li>Prepare dossiers per country laws
    19. 19. Registration with ‘local government’ (state / province)
    20. 20. Registration for private distribution in ‘cooperatives’</li></ul>AmbianceVentures<br />
    21. 21. REGULATORY & LEGAL COMPLIANCE:<br /><ul><li>Labeling requirements; Local / regional language translation
    22. 22. Periodic follow-up (weekly)
    23. 23. Most Governments DO NOT OPEN Letters of Credit
    24. 24. Customs documentation is CRITICAL
    25. 25. Comply with specified product delivery criteria
    26. 26. INCOMPLETE OR INACCURATE DOCUMENTATION CAN RESULT IN INORDINATE DELAYS IN PRODUCT LAUNCH, OR OUTRIGHT REJECTION
    27. 27. Delays in product delivery and improper storage at govt. appointed </li></ul>facilities can result in damage, loss of potency , product obsolescence – write off, returned product and additional cost for disposal or reverse logistics<br />AmbianceVentures<br />
    28. 28. PRIVATE MARKETS:<br />Influential in lobbying Federal and Provincial Governments, Regional Distributors<br /><ul><li>Agent / Distributor plays a crucial role
    29. 29. Reputation in private market supply chain
    30. 30. Supply logistics, cold chain, customer service
    31. 31. Institutional : Large insurance companies, Hospital chains
    32. 32. Retail: Pharmacy chains
    33. 33. Wholesalers: Physician offices
    34. 34. National level programs through private clinics
    35. 35. Create Local Advisory Boards; Strong connections with KOLs</li></ul>AmbianceVentures<br />
    36. 36. ACCOUNTS RECEIVABLES, COLLECTIONS:<br /><ul><li>Governments do not open Letters of Credit
    37. 37. Terms vary from 90 – 180 days credit
    38. 38. Sometimes bank guarantees can be obtained.
    39. 39. Assuming the Financial Risk - Agents / Distributors are experienced in collections </li></ul> from both government and private buyers<br /><ul><li>Private and institutional buyers want 90 – 120 days credit</li></ul>AmbianceVentures<br />
    40. 40. LOGISTICS:<br /><ul><li>Customs clearance – proper documentation
    41. 41. Receiving shipments, ensuring cold-chain at port / airport
    42. 42. Deal with port authority, associated bureaucrats and labor unions
    43. 43. Reduce risk of product damage and obsolescence
    44. 44. Freight consolidation – in-bound and out-bound
    45. 45. Re-packaging, re-dressing or special labeling in controlled environment
    46. 46. Storage permits and licenses
    47. 47. Cold chain validation
    48. 48. Proof of delivery procedures
    49. 49. Documentation:
    50. 50. Packaging list, Invoice, CoA, Customs Duty,
    51. 51. Point to point delivery: inland distribution to multiple final destinations
    52. 52. Return of expired, damaged or defective product
    53. 53. Disposal of expired, damaged or defective product</li></ul>AmbianceVentures<br />
    54. 54. PHARMACOVIGILANCE:<br />While an agent or distributor does not undertake fulltime PV responsibility,<br />they are the first responders within their specific region or country for <br />AE’s and SAE’s <br /><ul><li>Collecting defective product
    55. 55. Contacting reporting medical facility for liaison
    56. 56. Product recalls when necessary
    57. 57. Submit samples of ‘defective’ product to authorized labs.
    58. 58. Destruction of returned product if necessary</li></ul>AmbianceVentures<br />
    59. 59. Operational Objectives & Methodology:<br />(1) Discover: Data collection pertinent to Clients’ needs<br />(2) Diagnose: Analyze data and information to arrive at a cost-effective international strategy<br />(3) Design: Design the solution through application of strategy - a plan / proposal<br />(4) Deliver: Implement the solution through appropriate sales tactics.<br />APPROACH:<br /><ul><li>Capabilities presentation to examine opportunities to market vaccine</li></ul> products in select global markets in accordance with your strategy.<br /><ul><li>Identify potential partners / distributors for import of finished products or bulk vaccine for stockpile or re-distribution to private and public buyers in foreign markets
    60. 60. Design a step approach for future marketing needs in international markets.</li></ul>AmbianceVentures<br />
    61. 61. Who is……?<br />Our Operations in India<br />Principal Role: International Logistics & Distribution<br />Exports & Imports<br />Freight Consolidation<br />Customs Documentation & Clearance<br />Product Registration<br />Regulatory Filings<br />Bridging Studies, Bioequivalence Studies<br />Storage, Warehousing, Cold Chain Distribution.<br />Dependable source for Biologics, Pharmaceuticals, <br />Diagnostic Products and Hospital Supplies<br />AmbianceVentures USA<br />
    62. 62. INTRODUCTION: How we handle global business<br />Pennsylvania (USA) & Mumbai (India) based Global Business Development company with offices and operations in United States, United Kingdom, Philippines, Dubai and Affiliates in China.<br /> Specialized in International Business Development and Exports of Life Science products – Vaccines, Generics, Biologics, Diagnostics, and pharmaceutical machinery <br />End-to-end solution for:<br /><ul><li>Formulation, Analytical Development
    63. 63. Export APIs, Finished Products, POC / In-vitro Diagnostics
    64. 64. Contract Manufacture
    65. 65. Neutral Label & Private Label Manufacture
    66. 66. Global Marketing Assistance
    67. 67. Complete Export Documentation – Registration, Customs, Regulatory</li></ul>AmbianceVentures USA<br />
    68. 68. GLOBAL MARKETING, TRADE & BUSINESS STRATEGY<br />We market in the following countries:<br />North America: <br />United States, Canada, Mexico<br />European Union: <br />United Kingdom, Germany, Italy, Russia, Bulgaria, Hungary, Portugal, Spain, Ireland<br />Latin America / Central America:<br />Argentina, Brazil, Chile, Bolivia, Peru, Panama, Caribbean Is., Guyana, Surinam, Colombia<br />Asia, West Asia & Pacific: <br />Afghanistan, Bangladesh, Bhutan, Cambodia, China, Indonesia, Iran, Iraq, Jordan, <br />Middle East Nations, Malaysia, Philippines, Sri Lanka, Taiwan, Turkey, Vietnam<br />Africa:<br />Cameroons, Congo, Egypt, Ghana, Kenya, Libya, Mauritius, Morocco, Sudan, <br />South Africa, Uganda, Zambia<br />CIS Countries:<br />Ukraine, Russia, Kazakhstan, Uzbekistan, Armenia, Tajikistan<br />AmbianceVentures USA<br />
    69. 69. We Specialize in International Marketing:<br />Diversity of Our Product Range:<br /><ul><li>Branded and Generic Pharmaceuticals, Biologics, Biogenerics,
    70. 70. including Private Label, Neutral Label, Govt. Label
    71. 71. Biologics – Adult & Pediatric Vaccines, Sera and Anti-venoms
    72. 72. Our current focus: H1N1 (Swine Flu) Vaccine, Seasonal Flu Vaccine.
    73. 73. Hospital Supplies – Private Label and Generic
    74. 74. Pharmaceutical Ingredients: APIs, Empty Capsules, Excipients,
    75. 75. Fine Chemicals, Intermediates
    76. 76. Lab Supplies: Instrumentation, Reagents and Chemicals
    77. 77. Dental Products and supplies
    78. 78. Packaging Materials: Vials, Ampoules, Bottles, Blister packs, Aluminum Foils
    79. 79. Diagnostic Tests and Devices: HIV, Pregnancy, Diabetes, Malaria, STDs,
    80. 80. OTC and Personal Care Products – Branded, Generic and Private Label –
    81. 81. Custom manufactured at our own facilities in Dubai Tax Free Zone or India</li></ul>AmbianceVentures USA<br />
    82. 82. Outsource your Export Marketing, Regulatory and Customs formalities to us:<br />We have an established and reliable Worldwide infrastructure for Marketing and logistically sound Distribution, capable of handling large or small volumes.<br />Deep contacts and superior reputation within Governments and<br />Private Markets resulting from 28 years of international business dealings<br />Dependable Agents / Distributors across all continents who will pro-actively<br />promote your products to focused target segments, Ministries of Health and<br />non-governmental entities at Federal, Provincial and Local levels<br />The Best of Logistics in terms of Warehousing, Cold Chain for timely deliveries.<br />Expertise in Shipping, Scheduling, Consolidation for FCL shipments, Optimal<br />use of container space, Economical and timely Routing, Freight Insurance.<br />World-class Air and Sea Connections <br />Efficient Customs handling including pre-shipment inspections of product, <br />packaging, labeling, shipping marks<br />AmbianceVentures USA<br />
    83. 83. Former President of India – Dr. A.P.J. Kalam, and the <br />Hon. President of the Philippines – Gloria Macapagal Arroyo preside over signing of agreement with Valerian Lobo (Feb 2006)<br />LOB International was appointed ‘Authorized Sourcing Agent’ by <br />The Philippines Ministry of Health for supply of Pharmaceuticals, Biologics and Hospital supplies from India<br /> <br />AmbianceVentures USA<br />
    84. 84. Advantage – Ambiance Ventures: <br />U.S. Operations<br /><ul><li>By partnering with us, as a local producer, you will dominate with low prices, efficient logistics and production capabilities.
    85. 85. NEWEST PRODUCTS & FORMULATIONS – Far Superior to existing players!
    86. 86. Marketing of Vaccines to Government & Private markets
    87. 87. Rapid formulation, development and commercialization per US FDA standards
    88. 88. Client will own the Intellectual Property for formulation, development and manufacture.
    89. 89. Leverage local know-how in India to deal with bureaucracy and the government
    90. 90. Enjoy benefits of local manufacture and exports to other countries
    91. 91. Import finished products in Generics, Diagnostics and APIs</li></ul>AmbianceVentures USA<br />
    92. 92. OTHER SERVICES in Life sciences from<br />Our US Office:<br />Strategic Consulting & Market Development Services<br />Client Profile:<br />Biotechnology, Pharmaceutical, Medical Device and Healthcare<br />Companies in US, Canada, Latin America, India & China.<br />Areas of Expertise:<br />Contract Manufacture<br />Bulk Drugs, API Imports<br />Generic Drug Formulation, Development & Validation<br />Alliance Management: Identify partners, Due Diligence, Venture Capital<br />Country Representation: US, India, Latin America, Europe<br />Medical Conventions, Trade Shows, Speakership, Advisory Boards<br />Strategic Marketing, New Product Commercialization<br />Outsource Clinical Trial Design, Site Management, BA/BE Studies<br />Thought Leader Development, Business Intelligence<br />Expertise in multiple therapeutic areas<br />AmbianceVentures USA<br />
    93. 93. CONTRACT MANUFACTURE – <br />Why Outsource your Contract Manufacture to us in India?<br /><ul><li>Reduce capital expenditure and costs of manufacturing operations
    94. 94. Generic substitution, LOW COST, HIGH QUALITY, TIMELY PRODUCTION
    95. 95. Need to access specialized, economical mfg technology and methods
    96. 96. Have alternate mfg. sources in the event of supply interruptions
    97. 97. Unforeseen increase in demand
    98. 98. One-stop-shop for all PHARMA products and diagnostics needs
    99. 99. Our 28-year experience in sourcing for generics, contract mfr, combined</li></ul> with buying power in India, China, Thailand, and other promising supply<br /> sources globally. <br />AmbianceVentures USA<br />
    100. 100. Our Contract Partners offer following <br />STANDARDS OF MANUFACTURE & REGULATORY COMPLIANCE:<br /><ul><li>ISO 9001
    101. 101. ISO 13485
    102. 102. cGMP
    103. 103. ANVISA (Brazil)
    104. 104. FDA (United States)
    105. 105. EMEA (European Union)
    106. 106. SAHRPA (South Africa)
    107. 107. ANMAT (Argentina)</li></ul>AmbianceVentures USA<br />
    108. 108. Popular Categories of products exported globally through our offices:<br /><ul><li>Anti-retrovirals (HIV, AIDS), Anti-Virals (Oseltamivir, Zanamivir)
    109. 109. Anti-TB cocktails
    110. 110. Anti-Malaria cocktails
    111. 111. Biogenerics for Cancer
    112. 112. Cardiovascular
    113. 113. Antibacterials
    114. 114. Immunosuppressants
    115. 115. Hormonal, Infertility
    116. 116. Erectile Dysfunction
    117. 117. Sclerosants
    118. 118. Mucolytic agents
    119. 119. Anti-pyretics
    120. 120. Cough and Cold
    121. 121. Pediatric & Adult Vaccines
    122. 122. H1N1 (Swine Flu) Vaccine-2010-11 Season</li></ul>AmbianceVentures USA<br />
    123. 123. DISTRIBUTION & PRICING STRUCTURE<br />“Right products at the right price, within your quality specs”<br /><ul><li>Primary Consumption, Secondary Distribution
    124. 124. Specialists in Government Contracts, Private Market
    125. 125. Drop shipments
    126. 126. All Customs and Shipping Documentation
    127. 127. Labeling (in any language)</li></ul>Pricing Variants:<br /><ul><li>Name of Product (if branded) or Generic Name
    128. 128. Indication
    129. 129. Chemical name or composition
    130. 130. Form of Product (tablet, capsule, liquid, gel, powder) / Bulk
    131. 131. Strength (100mg, 250ml, etc.)
    132. 132. Quantity per shipment (kgs., litres, units)
    133. 133. Packaging (drums, bottles, strips) – MULTIDOSE, PRE-FILLS
    134. 134. Shipment Packaging requirements
    135. 135. Labeling Requirements – Regulatory Compliance</li></ul>AmbianceVentures USA<br />
    136. 136. DIAGNOSTIC TEST KITS<br /><ul><li>Blood Glucose
    137. 137. INFLUENZA
    138. 138. Pregnancy
    139. 139. HIV ( 1 & 2)
    140. 140. Hepatitis
    141. 141. Malaria
    142. 142. Dengue
    143. 143. Chikungunya
    144. 144. Syphillis
    145. 145. TB
    146. 146. Cardiac Markers
    147. 147. Dry Chemistry
    148. 148. Bio-chemistry
    149. 149. Hematology
    150. 150. Immunology, Rheumatology
    151. 151. ELISAs for Body Fluids</li></ul>Ideal for Rural Clinics, Pharmacies; can be manufactured ‘Private Label’<br />AmbianceVentures USA<br />
    152. 152. OUR SPECIALTY:<br />Leverage low cost contract manufacture at our facilities!<br />NEUTRAL LABEL, PRIVATE LABEL CONTRACT MANUFACTURE:<br />Vaccines, Generics, Cosmetics, Diagnostics, FMCG<br />Custom Packaging – For Re-distribution<br />Neutral (‘generic drug’) labelingper Ministry of Health requirements<br />of numerous Countries in multiple languages<br />In Portuguese / English / Spanish / French / Cyrillic / German / Arabic<br />Private labeling with your own Brand Name, Company Identity, <br />Compliant with regulations – Pharmacies, HMOs, Export, or for<br />Secondary Distribution<br />AmbianceVentures USA<br />
    153. 153. A Division of Ambiance Ventures <br />Distribution Offices in Mumbai (Bombay), India:<br /><ul><li>Fully staffed office (52 FT employees)
    154. 154. 5000 sq. feet of Warehouse space
    155. 155. Cold Chain refrigerated facility: 1500 sq. feet</li></ul>Sales and Logistics Office in Manila, Philippines:<br />We are Authorized Purchasing Agents for the Govt. of Philippines<br /><ul><li>All requirements from India by Philippines Ministry of Health are purchased</li></ul>through us – ‘one-stop-shop’ for vaccines, generics, hospital products from <br />multiple suppliers.<br /><ul><li>All logistics is coordinated by our Manila office.
    156. 156. All Philippine Govt. tenders are routed through us.</li></ul>Affiliate Offices in China:<br />Sourcing offices in Guangzhou, Yiwu, Shenzhen, Hong Kong, Shanghai<br />OTC, Dental Hygiene Contract Manufacturing Plant in Dubai<br />AmbianceVentures USA<br />
    157. 157. Our Business Model – <br />The Power of Bulk Buying and Bulk Freighting<br /><ul><li>28 Years of international business with integrity and efficiency
    158. 158. One-stop-shop for multiple products resourced from numerous mfrs.
    159. 159. We specialize in small orders and shipments - consolidated into container loads
    160. 160. Not all mfrs supply all your requirements. We source for you and consolidate smaller shipments for FCL rates
    161. 161. Helps your customers to minimize paperwork and transactions with multiple buyers – e.g. multiple letters of credit, multiple bills of lading
    162. 162. We take on the ‘headaches’ of logistics and excise /customs at port of origin even for smaller shipments to combine loads into affordable freight rates </li></ul>AmbianceVentures USA<br />
    163. 163. Our Business Model – <br />The Power of Bulk Buying and Bulk Freighting<br /><ul><li>Our volumes enable us to buy in bulk – hence better pricing, than if you were to direct buy from the manufacturer!
    164. 164. We pass the benefits on to you!
    165. 165. We represent manufacturers from India, China, Thailand, Europe, United States
    166. 166. All clients we represent are WHO, cGMP compliant, and many are ANVISA, US-FDA or EMEA approved
    167. 167. We work with you for Due Diligence including your visits to mfg. facilities in Asia for monitoring regulatory compliance, inspections
    168. 168. You can leverage low cost contract manufacturing at our facilities</li></ul>AmbianceVentures USA<br />
    169. 169. Affiliate of Ambiance Ventures USA <br />We are yourOffice Address in India<br /> As our Partner / Client, you may use our Offices and Warehouse facilities in Mumbai (Bombay) as your own:<br />On your Website<br />On Letterheads<br />In Correspondence and Applications<br />During visits to India by you or your clients<br /> Separate Phone and Fax lines for your company<br /> Assign a designated rep to respond on your behalf<br />AmbianceVentures USA<br />
    170. 170. BRAZIL - Update<br />Govt. Market H1N1: Brazil’s MinisteriodaSaude is buying a total of 83 million doses of vaccine against influenza A virus (H1N1), which will be used in a vaccination campaign planned for the period March to April 2010 – FIRST ROUND<br />Supply contracts: GSK, Sanofi Pasteur - 33 Million doses from Sanofi at $7.60 /dose via InstitutoButantan for first responders and susceptible population<br />PAHO to provide 10 Million doses later(??)<br />Potential for at least 5-6 Million more doses if price is right!<br />(Priority groups such as pregnant women, health workers involved in patient care, children from 6 months to 2 years, indigenous people and people with chronic pre-existing conditions (cardiac, pulmonary, renal, metabolic, etc.) Details of strategy will be announced early February).<br />Private Market H1N1: 12-15 Million doses<br />Seasonal:Public: 17 Million doses; Private: 3 Million doses<br />AmbianceVentures USA<br />
    171. 171. Region Main Cities Population<br />SE: 1-Sao Paulo 10.434.252 <br />Metro area: 20.237.000<br /> 2-Rio de Janeiro 6.136.652 <br /> 3-Belo Horizonte 2.399.920 <br />SO: 4-Curitiba 1.788.559 <br /> 5-Porto Alegre 1.440.939 <br />NE: 6-Recife: 1.515.052 <br /> 7-Salvador: 2.711.372 <br /> 8-Fortaleza: 2.416.920 <br />FD: 9-Brasilia: 2.363.108<br />Total: 41,009,522<br />GDP/Capita $13,400<br />Spain 40,397,842<br />GDP/Capita $25,600 <br />Demographic data:<br /><ul><li> Population: 191.297.098
    172. 172. Age structure:0-14 years: 25.8% male 24,6M / female 23,7M </li></ul>15-64 years: 68.1% male 63,5M / female 64,6M <br />65 years and over: 6.1% male 4,7M / female 6,7M (2006 est.) <br /><ul><li> Population growth rate: 1.04% (2006 est.) ;
    173. 173. Birth rate: 16.56 births/1,000 population (2006 est.)
    174. 174. Death rate: 6.17 deaths/1,000 population (2006 est.) </li></ul>AmbianceVentures USA<br />
    175. 175. Sales Force Structure: Our Operations in Brazil<br />Field Force Distribution<br />Field Force<br />Medical Reps: 50 <br />Sales Coordinators: 02<br />Sales National Manager: 01<br />Product Manager: 01<br />Total: 54<br />AmbianceVentures USA<br />
    176. 176. Brazilian Vaccines Market<br />Estimating a CARG 6.5%/Year: The Market in 2008  $ 330 million (US$ =2.00)<br />AmbianceVentures USA<br />
    177. 177. Latin America Business Development Model <br />1- Regional (multinational) Innovative Partnership [ Win-Win Project – WWP]<br />1- A new core product is located by one of the partners (PA, PB, PC. PD…)<br />2- The International Project Team is activated (country representatives)<br />3- Marketing, Sales and Regulatory evaluation is performed in each country by the team.<br />4- The Regional Dossier with Regulatory, MKT & Sales potential is provided to the Global Company<br />5- Contract is signed and the Registration and Pre-MKT activities are started <br />PD<br />PA<br />PC<br />PE<br />PF<br />PB<br />PG<br />PH<br />PJ<br />PI<br />Argentina<br />Mexico<br />UM<br />Br<br />Chile<br />Colombia<br />Brazil Mexico Argentina Colombia Chile<br />US$ 20.5 billion US$ 19.2 billion US$ 4.2 billion US$ 2.1 billion US$ 1.6 billion <br />Our connections in Mercosur govts., and rest of Latin America (for swine flu & seasonal vaccines).<br />AmbianceVentures USA<br />
    178. 178. LATIN AMERICA<br />Strong Market Leadership in Brazil, Argentina, Mexico <br />(75% population of Latin America)<br />Market Development:<br />Stage 1: Brazil, Mexico, Argentina<br />Stage 2: Colombia, Chile, Bolivia, Venezuela, Central America<br />Stage 3: Other LatAm countries<br />AmbianceVentures USA<br />
    179. 179. LATIN AMERICA<br />Therapeutic Areas / Markets of interest:<br /><ul><li> Vaccines – Complete Portfolio
    180. 180. Cardiovascular
    181. 181. Anaphylaxis and Emergency Care
    182. 182. Plasma-derived Therapeutics
    183. 183. AntiVenoms</li></ul>AmbianceVentures USA<br />
    184. 184. ASIA, MIDDLE EAST, CIS, AFRICA<br />INDIA: Government Licensed Importer, Distributor with strong network.<br />28 years in Pharma, Biotech Distribution, Imports and Exports<br />High level connections<br />ASEAN Countries: Government Authorized Sourcing agents in Philippines, ASEAN Nations<br />Marketing / Distribution set - up in:<br /><ul><li>ASEAN (14 countries)
    185. 185. Russia, Other CIS countries, Central Eastern Europe
    186. 186. Eurasia & PacRim
    187. 187. Middle East
    188. 188. Africa</li></ul>AmbianceVentures USA<br />
    189. 189. GLOBAL MARKETING, TRADE & BUSINESS STRATEGY<br />We market in the following countries:<br />North America: <br />United States, Canada, Mexico<br />European Union: <br />United Kingdom, Germany, Italy, Russia, Bulgaria, Hungary, Portugal, Spain, Ireland<br />Latin America / Central America:<br />Argentina, Brazil, Chile, Bolivia, Peru, Panama, Caribbean Is., Guyana, Surinam, Colombia<br />Asia, West Asia & Pacific: <br />Afghanistan, Bangladesh, Bhutan, Cambodia, China, Indonesia, Iran, Iraq, Jordan, <br />Middle East Nations, Malaysia, Philippines, Sri Lanka, Taiwan, Turkey, Vietnam<br />Africa:<br />Cameroons, Congo, Egypt, Ghana, Kenya, Libya, Mauritius, Morocco, Sudan, <br />South Africa, Uganda, Zambia<br />CIS Countries:<br />Ukraine, Russia, Kazakhstan, Uzbekistan, Armenia, Tajikistan<br />AmbianceVentures USA<br />
    190. 190. Contact: Jay Nadkarni<br />Ambiance Ventures, USA<br />P.O. Box 622, Swiftwater, Pennsylvania 18370 (USA)<br />Tel: 570/ 460-1804<br />Jay@AmbianceVentures.com; www.AmbianceVentures.com<br />Contact: Valerian Lobo<br />LOB International, India<br />G-6 Khira Industrial Estates, B.M. Bhargava Rd.<br />Santa Cruz (W), Mumbai 400 054 (INDIA)<br />Tel: 9122- 2661-5006, 9122-2661-6008<br />Val@Lobin.com; www.lobin.com<br />AmbianceVentures USA<br />
    191. 191. THANK YOU<br />Questions?<br />Contact:<br />JAY NADKARNI<br />Cell: (570) 460-1804<br />Jay@AmbianceVentures.com<br />AmbianceVentures USA<br />
    1. A particular slide catching your eye?

      Clipping is a handy way to collect important slides you want to go back to later.

    ×